메뉴 건너뛰기




Volumn 9, Issue 9, 2010, Pages 675-676

The antibiotics market

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CEFCAPENE PIVOXIL; CEFTAROLINE; CEFTOBIPROLE; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CETHROMYCIN; DALBAVANCIN; DAPTOMYCIN; FIDAXOMICIN; ICLAPRIM; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MONOCLONAL ANTIBODY; MOXIFLOXACIN; ORITAVANCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAMOPLANIN; RETAPAMULIN; TELAVANCIN; TIGECYCLINE; UNCLASSIFIED DRUG; VACCINE; VIBATIV; ANTIINFECTIVE AGENT;

EID: 77956307436     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3267     Document Type: Short Survey
Times cited : (233)

References (6)
  • 1
    • 84925571054 scopus 로고    scopus 로고
    • IMS Health. IMS MIDAS (2009)
    • IMS Health. IMS MIDAS (2009).
  • 2
    • 42549171131 scopus 로고    scopus 로고
    • Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
    • Rice, L. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197,1079-1081 (2008).
    • (2008) J. Infect Dis. , vol.197 , pp. 1079-1081
    • Rice, L.1
  • 3
    • 0242291985 scopus 로고    scopus 로고
    • Why is big pharma getting out of antibacterial drug discovery?
    • Projan, S. Why is big pharma getting out of antibacterial drug discovery? Curr. Opin. Microbiol. 6, 427-430 (2003).
    • (2003) Curr. Opin. Microbiol. , vol.6 , pp. 427-430
    • Projan, S.1
  • 4
    • 77954882772 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) FDA website [online]
    • US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for industry: non-inferiority clinical trials. FDA website [online], http://www.fdanews.com/ext/files/NoninferiorityGuidance. pdf (2010).
    • (2010) Guidance for Industry: Non-inferiority Clinical Trials
  • 5
    • 77649223473 scopus 로고    scopus 로고
    • Biologics target bad bugs
    • Extance, A. Biologics target bad bugs. Nature Rev. Drug Discov. 9, 177-178 (2010).
    • (2010) Nature Rev. Drug Discov. , vol.9 , pp. 177-178
    • Extance, A.1
  • 6
    • 84925571053 scopus 로고    scopus 로고
    • IMS Health. IMS LifeCycle (2009)
    • IMS Health. IMS LifeCycle (2009).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.